Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: PERFUSION MEDICAL LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-09-15 to 2026-07-14
Current total value of award: $2986772.93
Description: DEFENSE HEALTH AGENCY SMALL BUSINESS INNOVATION RESEARCH DIRECT TO PHASE II, PROPOSAL H2D-0122, TITLED"IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC", MEDICAL RESEARCH AND DEVELOPMENT CONTRACT.